Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Serum neuroleptic and anticholinergic activity in relationship to cognitive toxicity of antiparkinsonian agents in schizophrenic patients.

Hitri A, Craft RB, Fallon J, Sethi R, Sinha D.

Psychopharmacol Bull. 1987;23(1):33-7. No abstract available.

PMID:
2885890
2.

Drug levels and antiparkinsonian drugs in neuroleptic-treated schizophrenic patients.

Hitri A, Craft RB, Sethi R, Sinha D.

Clin Neuropharmacol. 1987 Jun;10(3):261-71.

PMID:
2900683
5.

Anticholinergic effects on memory: benztropine versus amantadine.

Gelenberg AJ, Van Putten T, Lavori PW, Wojcik JD, Falk WE, Marder S, Galvin-Nadeau M, Spring B, Mohs RC, Brotman AW.

J Clin Psychopharmacol. 1989 Jun;9(3):180-5.

PMID:
2661606
6.

Psychoactive properties of benztropine and trihexyphenidyl.

Wilcox JA.

J Psychoactive Drugs. 1983 Oct-Dec;15(4):319-21. No abstract available.

PMID:
6655530
7.

Actions of trihexyphenidyl and benztropine on squid axon membranes.

Wu CH, Narahashi T.

J Pharmacol Exp Ther. 1976 Apr;197(1):135-41.

PMID:
1263127
8.

The withdrawal of benztropine mesylate in chronic schizophrenic patients.

Baker LA, Cheng LY, Amara IB.

Br J Psychiatry. 1983 Dec;143:584-90.

PMID:
6362765
9.

The dose-response relationship for memory impairment by anticholinergic drugs.

McEvoy JP, Freter S.

Compr Psychiatry. 1989 Mar-Apr;30(2):135-8.

PMID:
2920548
10.

Mood elevation and medication.

Dugas JE.

Dis Nerv Syst. 1977 Nov;38(11):958. No abstract available.

PMID:
21060
11.

Anticholinergic challenge and neuroleptic withdrawal. Changes in dyskinesia and symptom measures.

Gardos G, Cole JO, Rapkin RM, LaBrie RA, Baquelod E, Moore P, Sovner R, Doyle J.

Arch Gen Psychiatry. 1984 Nov;41(11):1030-5.

PMID:
6149737
13.

Differential memory function with dopaminergic versus anticholinergic treatment of drug-induced extrapyramidal symptoms.

Fayen M, Goldman MB, Moulthrop MA, Luchins DJ.

Am J Psychiatry. 1988 Apr;145(4):483-6.

PMID:
2894780
14.

Adverse effects of anticholinergic antiparkinsonian drugs in tardive dyskinesia. An investigation of mechanism.

Burnett GB, Prange AJ Jr, Wilson IC, Jolliff LA, Creese IC, Synder SH.

Neuropsychobiology. 1980;6(2):109-20.

PMID:
6101910
15.
16.

Screening for cognitive toxicity of anticholinergic drugs.

Katz IR, Greenberg WM, Barr GA, Garbarino C, Buckley P, Smith D.

J Clin Psychiatry. 1985 Aug;46(8):323-6.

PMID:
2862135
17.

Clozapine in patients with chronic schizophrenia: serum level, EEG and memory performance.

Adler G, Grieshaber S, Faude V, Thebaldi B, Dressing H.

Pharmacopsychiatry. 2002 Sep;35(5):190-4.

PMID:
12237790
18.

Anticholinergic effects on memory: benztropine vs. amantadine.

Van Putten T, Gelenberg AJ, Lavori PW, Falk WE, Marder SR, Spring B, Mohs RC, Brotman AW.

Psychopharmacol Bull. 1987;23(1):26-9. No abstract available.

PMID:
3602326
19.

Effects of amantadine and trihexyphenidyl on memory in elderly normal volunteers.

McEvoy JP, McCue M, Spring B, Mohs RC, Lavori PW, Farr RM.

Am J Psychiatry. 1987 May;144(5):573-7.

PMID:
3578566

Supplemental Content

Support Center